Alzamend Neuro

ALZN

ALZN Alzamend Neuro NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    ALZN Chart
    See on advanced chart >

    About

    Alzamend Neuro, Inc. was incorporated on February 26, 2016 under the laws of the State of Delaware. The company is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease, bipolar disorder,...
    • Highlight
      An early clinical-stage biopharmaceutical company that developing novel products for the Alzheimer's disease, bipolar disorder, major depressive disorder and post-traumatic stress disorder
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/15/2021
    • Established Date
      02/26/2016
    • Full-time Employees
      4
    • Address
      3480 Peachtree Road NE Second Floor Suite 103 Atlanta GA 30326
    • Tel
      1-844-7226333
    • Website
    • Fiscal Year End Date
      04/30
    • Security Type
      Common Stock
    cache time: 2024-04-14 11:01:09